Clinical Trial Update: The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients [NA]

View source ↗

Summary

This clinical trial update explores the potential value of PET/CT in the follow-up care of patients with Stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Radboud University Medical Center | Conditions: Stage III Non-small Cell Lung Cancer | NA | Status: RECRUITING